To determine if our in vitro data had in vivo relevance, COX-1, COX-2, EP1 receptor and FasL expression was analysed by immunohistochemistry on sequential sections from 27 human colon cancer tissues. The gene discussed is FASLG; the disease is malignant colon neoplasm.